Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2002
03/14/2002WO2002020799A2 Nucleotide sequences which code for the luxs gene
03/14/2002WO2002020798A1 A novel polypeptide- human dehydrogenase 56 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020797A2 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production
03/14/2002WO2002020796A2 Methanotrophic carbon metabolism pathway genes and enzymes
03/14/2002WO2002020795A1 A novel polypeptide- hexokinase protein 9.68 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020794A1 A NOVEL POLYPEPTIDE- HUMAN ACYL CoA SYNTHETASE 11.77 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
03/14/2002WO2002020775A1 A novel polypeptide- cyclin-dependent kinase-cdk411 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020771A2 Nucleotide sequences coding for the hisc2 gene
03/14/2002WO2002020758A2 Novel proteins and nucleic acids encoding same
03/14/2002WO2002020755A2 Phenol oxidizing enzyme variants
03/14/2002WO2002020747A2 Regulation of human tyrosine phosphatase-like enzyme
03/14/2002WO2002020746A1 Lubricated granules
03/14/2002WO2002020745A1 Human soluble testicular adenylyl cyclase
03/14/2002WO2002020744A1 Novel polypeptide--- a human endo type protease 23.32 and polynucleotide encoding it
03/14/2002WO2002020743A1 A new polypeptide- human i kappa b kinase 15 and the polynucleotide encoding it
03/14/2002WO2002020742A1 Use of ip3 kinases for preparing medicines for treating oxidative stress-related diseases
03/14/2002WO2002020741A1 Hydroxy-phenyl pyruvate dioxygenase fused with a signal peptide, dna sequence and use for obtaining plants containing herbicide-tolerant plants
03/14/2002WO2002020740A2 Proteolysis targeting chimeric pharmaceutical
03/14/2002WO2002020739A2 Human matrix metalloproteinase
03/14/2002WO2002020738A2 27877, a phospholipase and uses therefor
03/14/2002WO2002020736A2 Proteases
03/14/2002WO2002020735A2 Enzymes having high temperature polymerase activity and methods of use thereof
03/14/2002WO2002020733A2 Genes involved in isoprenoid compound production
03/14/2002WO2002020732A2 Regulation of human map kinase phosphatase-like enzyme
03/14/2002WO2002020731A2 Regulation of human protein disulfide isomerase-like enzyme
03/14/2002WO2002020730A2 Manganese lipoxygenase
03/14/2002WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a
03/14/2002WO2002020726A2 Method for increasing the effectiveness of antiinfective agents
03/14/2002WO2002020721A2 Vectors derived from south african arbovirus no. 86
03/14/2002WO2002020717A2 Methods for simultaneous control of lignin content and composition, and cellulose content in plants
03/14/2002WO2002020711A2 Detergent compositions comprising phenol oxidizing enzymes
03/14/2002WO2002020616A1 Hla-a2.1 binding peptides and their uses
03/14/2002WO2002020607A1 A NEW POLYPEPTIDE-HUMAN BIPHENYL HYDROLASE-RELATED PROTEIN (Bph-rp)16.06 AND THE POLYNUCLEOTIDE ENCODING IT
03/14/2002WO2002020602A1 A novel peptide---human short chain dehydrogenase 9.9 and the polynucleotide coding this novel peptide
03/14/2002WO2002020594A1 A novel polypeptide-homodna topoisomerase ii-beta(top2b)29.48 and polynucleotide encoding said polypeptide
03/14/2002WO2002020590A1 A novel polypeptide-phosphoenolpyruvate-dependent sugar phosphotransferase 33 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020587A1 A novel polypeptide-human nadh dehydrogenase subunit i-12.43 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020581A1 A novel polypeptide-rna polymerase 11 related protein 11.33 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020579A1 A novel polypeptide-homo acid phosphatase family protein 11 and polynucleotide encoding said polypeptide
03/14/2002WO2002020578A1 A novel polypeptide-homo mitochondria aspartate aminotransferase 37.29 and polynucleotide encoding said polypeptide
03/14/2002WO2002020577A1 A novel polypeptide-homo ribonucleotide reductase 10.49 and polynucleotide encoding said polypeptide
03/14/2002WO2002020574A1 Nucleotide sequences which code for the clpc gene
03/14/2002WO2002020573A2 Nucleotide sequences which code for the gpmb gene
03/14/2002WO2002020572A2 Nucleotide sequences coding for the chrs gene
03/14/2002WO2002020548A1 Monocot seeds with increased lignan content
03/14/2002WO2002020542A2 Nucleotide sequences which code for the gap2 gene
03/14/2002WO2002020495A2 Inhibitors of glycogen synthase kinase 3
03/14/2002WO2002020475A2 Inhibitors of serine protease activity of matriptase or mtsp1
03/14/2002WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
03/14/2002WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject
03/14/2002WO2002019822A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/14/2002WO2001095691A3 Fructosyl transferase homologues from ryegrass (lolium) and fescue (festuca) species
03/14/2002WO2001094538A3 A novel polypeptide, dna ligase 21 and the polynucleotide encoding the polypeptide
03/14/2002WO2001079506A3 Treatment of ocular neovascularization and related diseases
03/14/2002WO2001079505A3 INHIBITION OF BONE TUMOR FORMATION USING ANTISENSE cDNA THERAPY
03/14/2002WO2001079502A3 Vectors for gene therapy
03/14/2002WO2001079219A3 Haplotypes of the ache gene
03/14/2002WO2001075060A3 A novel polypeptide, human cystein protease 9 and the polynucleotide encoding the polypeptide
03/14/2002WO2001075022A3 A novel polypeptide, human eucaryotic acetyl transferase 12 and the polynucleotide encoding the polypeptide
03/14/2002WO2001073075A3 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
03/14/2002WO2001070944A3 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
03/14/2002WO2001064902A3 46867, a transferase family member and uses therefor
03/14/2002WO2001059129A3 Mammalian secreted group iii phospholipase a2
03/14/2002WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
03/14/2002WO2001059064A3 Nucleic acids, proteins, and antibodies
03/14/2002WO2001058921A9 Methods and compositions for generating angiostatin
03/14/2002WO2001058275A9 Use of acid-stable subtilisin proteases in animal feed
03/14/2002WO2001057081A3 Narc-1, subtilase-like homologs
03/14/2002WO2001055410A3 Ceramidase compositions and methods based thereon
03/14/2002WO2001055358A3 Phosphodiesterases
03/14/2002WO2001055312A3 Nucleic acids, proteins, and antibodies
03/14/2002WO2001053524A3 Cancer associated genes and their products
03/14/2002WO2001048162A3 Method for the production of vitamin a
03/14/2002WO2001044497A3 Protein kinase regulation
03/14/2002WO2001025444A3 Novel human phosphodiesterase zcytor13
03/14/2002WO2001012788A3 Tryptase-like polypeptide ztryp1
03/14/2002WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase
03/14/2002WO2000055353A9 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
03/14/2002WO1997003998A9 Modulators of the function of fas receptors and other proteins
03/14/2002US20020032914 Transgenic mice containing ubiquitin-specific protease 16 gene disruptions
03/14/2002US20020032151 Using an agent which promotes tyrosine protein dephosphorylation in the preparation of a medicament for reducing permeability of a physiological barrier such as the blood-brain barrier
03/14/2002US20020031832 Method of stable integration of DNA into neurons
03/14/2002US20020031826 Glucan-containing compositions and paper
03/14/2002US20020031817 Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
03/14/2002US20020031816 Method of inhibition of human glycogen phosphorylase
03/14/2002US20020031815 46619, a novel human beta-ketoacyl synthase and uses thereof
03/14/2002US20020031810 Nucleotide sequences coding for the lipA gene
03/14/2002US20020031809 Nucleotide sequences coding for the lipB gene
03/14/2002US20020031807 Proteases from gram-positive organisms
03/14/2002US20020031801 Nucleotide sequences coding enzymatic polypeptide for use in modulating immune response and cellular differentiation; for use in the diagnosis and treatment of blood, immune response, cell differentiation and proliferation defects
03/14/2002US20020031799 Mammalian coagulation protein; for use in treatment of blood disorders
03/14/2002US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase
03/14/2002US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use
03/14/2002US20020031782 Complexing
03/14/2002US20020031771 Nucleic acid profile of preferential sample; obtain nucleotide sequences from sample, sequence, compare sequence with those in sequence libraries, detect homology
03/14/2002US20020031768 Method for quantitative analysis of a nucleic acid amplification reaction
03/14/2002US20020031507 Treatment of inflammatory processes of the intestine, hypercholesterolaemia and infections with Helicobacter pylori; anticarcinogenic agent
03/14/2002US20020031506 Human glutathione peroxidase-6
03/14/2002US20020031494 Nucleic acids for reducing carbohydrate epitopes
03/14/2002DE10109690A1 Neue für das metY-Gen kodierende Nukleotidsequenzen New coding for the metY gene nucleotide sequences
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1416